Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019
(COVID-19). There is currently no drug that has been proven as an effective therapy for
COVID-19. Several candidate drugs are being considered and evaluated for treatment. This
includes clinically available drugs, such as chloroquine, hydroxychloroquine, and
lopinavir/ritonavir, which are being repurposed for the treatment of COVID-19. Novel …

[引用][C] Treatment considerations for COVID-19: a critical review of the evidence (or Lack Thereof) in Mayo clinic proceedings

P Vijayvargiya - 2020 - Amsterdam: Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果